These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Redefining dysferlinopathy phenotypes based on clinical findings and muscle imaging studies. Paradas C; Llauger J; Diaz-Manera J; Rojas-García R; De Luna N; Iturriaga C; Márquez C; Usón M; Hankiewicz K; Gallardo E; Illa I Neurology; 2010 Jul; 75(4):316-23. PubMed ID: 20574037 [TBL] [Abstract][Full Text] [Related]
44. [Whole-body MRI in children with langerhans cell histiocytosis for the evaluation of the skeletal system]. Steinborn M; Wörtler K; Nathrath M; Schöniger M; Hahn H; Rummeny EJ Rofo; 2008 Jul; 180(7):646-53. PubMed ID: 18561067 [TBL] [Abstract][Full Text] [Related]
45. Update of the Pompe disease mutation database with 107 sequence variants and a format for severity rating. Kroos M; Pomponio RJ; van Vliet L; Palmer RE; Phipps M; Van der Helm R; Halley D; Reuser A; Hum Mutat; 2008 Jun; 29(6):E13-26. PubMed ID: 18425781 [TBL] [Abstract][Full Text] [Related]
46. Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system. Braun J; Baraliakos X; Golder W; Brandt J; Rudwaleit M; Listing J; Bollow M; Sieper J; Van Der Heijde D Arthritis Rheum; 2003 Apr; 48(4):1126-36. PubMed ID: 12687557 [TBL] [Abstract][Full Text] [Related]
47. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology. Schmidt GP; Kramer H; Reiser MF; Glaser C Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383 [TBL] [Abstract][Full Text] [Related]
48. Bright tongue sign in Pompe disease. Karam C Neurology; 2016 Jan; 86(4):401. PubMed ID: 26810423 [No Abstract] [Full Text] [Related]
49. Follow-up of late-onset Pompe disease patients with muscle magnetic resonance imaging reveals increase in fat replacement in skeletal muscles. Nuñez-Peralta C; Alonso-Pérez J; Llauger J; Segovia S; Montesinos P; Belmonte I; Pedrosa I; Montiel E; Alonso-Jiménez A; Sánchez-González J; Martínez-Noguera A; Illa I; Díaz-Manera J J Cachexia Sarcopenia Muscle; 2020 Aug; 11(4):1032-1046. PubMed ID: 32129012 [TBL] [Abstract][Full Text] [Related]
50. Diagnostic criteria for late-onset (childhood and adult) Pompe disease. American Association of Neuromuscular & Electrodiagnostic Medicine Muscle Nerve; 2009 Jul; 40(1):149-60. PubMed ID: 19533647 [TBL] [Abstract][Full Text] [Related]
51. Expanding the phenotype of late-onset Pompe disease: tongue weakness: a new clinical observation. Dubrovsky A; Corderi J; Lin M; Kishnani PS; Jones HN Muscle Nerve; 2011 Dec; 44(6):897-901. PubMed ID: 21953123 [TBL] [Abstract][Full Text] [Related]
53. [Groin pain in athletes: role of magnetic resonance]. Barile A; Erriquez D; Cacchio A; De Paulis F; Di Cesare E; Masciocchi C Radiol Med; 2000 Oct; 100(4):216-22. PubMed ID: 11155446 [TBL] [Abstract][Full Text] [Related]
54. Lung MRI and impairment of diaphragmatic function in Pompe disease. Wens SC; Ciet P; Perez-Rovira A; Logie K; Salamon E; Wielopolski P; de Bruijne M; Kruijshaar ME; Tiddens HA; van Doorn PA; van der Ploeg AT BMC Pulm Med; 2015 May; 15():54. PubMed ID: 25943437 [TBL] [Abstract][Full Text] [Related]
55. Skeletal muscle magnetic resonance imaging in Pompe disease. Díaz-Manera J; Walter G; Straub V Muscle Nerve; 2021 May; 63(5):640-650. PubMed ID: 33155691 [TBL] [Abstract][Full Text] [Related]
56. Quantification of Diaphragm Mechanics in Pompe Disease Using Dynamic 3D MRI. Mogalle K; Perez-Rovira A; Ciet P; Wens SC; van Doorn PA; Tiddens HA; van der Ploeg AT; de Bruijne M PLoS One; 2016; 11(7):e0158912. PubMed ID: 27391236 [TBL] [Abstract][Full Text] [Related]